Hormonal influences on cancer progression and prognosis

G V Sherbet1

  • 1School of Electrical, Electronic, and Computer Engineering, University of Newcastle upon Tyne, Newcastle upon Tyne NE7 6RU, United Kingdom.

Vitamins and Hormones
|August 23, 2005
PubMed

Insights

Growth factors, hormones, and vitamins regulate cell functions, but their deregulation drives cancer progression. Understanding these molecular changes may reveal new cancer markers and treatments.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • Cellular processes like differentiation, proliferation, apoptosis, and motility are controlled by growth factors, vitamins, and hormones.
  • Deregulation of these signaling pathways contributes to tumor development, characterized by abnormal cell proliferation, altered adhesion, extracellular matrix remodeling, and metastasis.

Purpose of the Study:

  • To review the role of growth factors, vitamins, and hormones in regulating cellular functions.
  • To discuss the implications of deregulation of these factors in cancer progression and metastasis.
  • To explore potential new markers and therapeutic strategies based on molecular changes in hormone- and vitamin-driven cancers.

Main Methods:

  • Literature review focusing on molecular mechanisms of cancer progression.
  • Analysis of signaling pathways influenced by hormones and vitamins.
  • Correlation of molecular changes with biological events in cancer invasion and progression.

Main Results:

  • Deregulation of growth factors, hormones, and vitamins leads to key events in cancer development, including altered cell proliferation and invasiveness.
  • Molecular changes in hormone- and vitamin-responsive genes are linked to cancer invasion and progression.
  • The relationship between genetic changes and biological events in cancer progression is highlighted.

Conclusions:

  • The deregulation of cellular regulators is central to cancer progression.
  • Identifying molecular changes associated with hormone- and vitamin-driven responses can lead to novel progression markers.
  • These findings may inform the development of new patient management strategies for cancer.

Related Concept Videos

Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Psychoneuroimmunology: Diabetes and Cancer01:19

Psychoneuroimmunology: Diabetes and Cancer

Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.